Trenbolone

Trenbolone

Trenbolone is a anabolic steroid used by veterinarians on livestock to increase muscle growth and appetite. To increase its effective half-life, trenbolone is not used in an unrefined form, but is rather administered as ester derivatives such as trenbolone acetate, trenbolone enanthate, or trenbolone cyclohexylmethylcarbonate. Trenbolone and its derivatives are considered Schedule III drugs under the Controlled Substances Act.

History

Trenbolone was first synthesized in 1963 by Hoechst-Roussel. The company started to produce the trenbolone acetate under the names Finajet and Finaject in the France. In the late 1980s, the company discontinued the production of this drug.

Pharmacology

Trenbolone exhibits interesting pharmacodynamics. It has both androgenic and anabolic effects. Once metabolized, the drug has the effect of increasing ammonium ion uptake by muscle, leading to an increase in the rate of protein synthesis. It also has the secondary effects of stimulating appetite and decreasing the rate of catabolism, as all anabolic steroids are believed to; however, catabolism likely increases significantly once the steroid is no longer taken.

Side Effects

Trenbolone has several potential side effects, many of which are typical for all anabolic steroids. These include oily skin, aggressive behavior, acne, and hair loss. Trenbolone is also notorious for causing a temporary increase in thyroid hormone levels, which can then cause an increase in prolactin levels.

Legal Status

In the United States, trenbolone is classified as a Schedule III drug under the Controlled Substances Act. It is also a controlled substance in Canada under Schedule IV. In the United Kingdom, trenbolone is classified as a Class C drug.

See Also

• Anabolic steroid
• Controlled Substances Act
• Hoechst AG

‎